Published in Naunyn Schmiedebergs Arch Pharmacol on April 26, 2013
Reduced motivation in the BACHD rat model of Huntington disease is dependent on the choice of food deprivation strategy. PLoS One (2014) 0.79
Further investigation of phenotypes and confounding factors of progressive ratio performance and feeding behavior in the BACHD rat model of Huntington disease. PLoS One (2017) 0.75
Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature (2001) 6.36
Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc Natl Acad Sci U S A (1974) 5.73
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest (2005) 4.55
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol (2002) 3.33
Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. Hepatology (2007) 2.48
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes (2006) 2.40
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord (2004) 2.38
Insulin receptor deficiency in genetic and acquired obesity. J Clin Invest (1975) 1.79
The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. FASEB J (2005) 1.56
Pharmacotherapies for obesity: past, current, and future therapies. J Obes (2010) 1.43
Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats. Diabetes (2008) 1.39
CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice. Diabetes (2010) 1.29
Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y). FASEB J (2001) 1.27
Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells. Diabetes (2011) 1.26
Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats. Endocrinology (2008) 1.23
The case for peripheral CB₁ receptor blockade in the treatment of visceral obesity and its cardiometabolic complications. Br J Pharmacol (2011) 1.21
Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences. Br J Pharmacol (2007) 1.07
The current status and future perspectives of studies of cannabinoid receptor 1 antagonists as anti-obesity agents. Curr Top Med Chem (2009) 1.05
Cannabinoids induce pancreatic β-cell death by directly inhibiting insulin receptor activation. Sci Signal (2012) 0.97
The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake. Pharmacol Biochem Behav (2006) 0.97
Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice. Basic Clin Pharmacol Toxicol (2008) 0.93
Hypothalamic obesity in patients with craniopharyngioma: profound changes of several weight regulatory circuits. Front Endocrinol (Lausanne) (2011) 0.93
Role of cannabinoids in chronic liver diseases. World J Gastroenterol (2008) 0.93
GLUT4 content decreases along with insulin resistance and high levels of inflammatory markers in rats with metabolic syndrome. Cardiovasc Diabetol (2012) 0.93
HMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway. Sci Rep (2012) 0.92
The effects of rimonabant on brown adipose tissue in rat: implications for energy expenditure. Obesity (Silver Spring) (2008) 0.92
Alterations in the hepatic insulin receptor kinase in genetic and acquired obesity in rats. Endocrinology (1989) 0.88
Rimonabant: From RIO to Ban. J Obes (2011) 0.88
Late effects of postnatal administration of monosodium glutamate on insulin action in adult rats. Physiol Res (2000) 0.88
The PPARalpha/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats. Br J Pharmacol (2006) 0.86
Sensory and autonomic nerve changes in the monosodium glutamate-treated rat: a model of type II diabetes. Exp Physiol (2007) 0.84
Effects of chronic treatment with the CB1 antagonist, rimonabant on the blood pressure, and vascular reactivity of obese Zucker rats. Obesity (Silver Spring) (2009) 0.83
A novel rodent model that mimics the metabolic sequelae of obese craniopharyngioma patients. Pediatr Res (2011) 0.82
Rimonabant. Drugs (2006) 0.81
Studies of different female rat models of hypothalamic obesity. J Pediatr Endocrinol Metab (2011) 0.81
Genome-wide expression profiling revealed peripheral effects of cannabinoid receptor 1 inverse agonists in improving insulin sensitivity and metabolic parameters. Mol Pharmacol (2010) 0.81
Pentamethylquercetin generates beneficial effects in monosodium glutamate-induced obese mice and C2C12 myotubes by activating AMP-activated protein kinase. Diabetologia (2012) 0.80
Harmful effects of MSG on function of hypothalamus-pituitary-target gland system. Biomed Environ Sci (1995) 0.79
Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia. J Obes (2010) 0.79
Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activity. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.78
Neonatal treatment with monosodium glutamate increases plasma corticosterone in the rat. Neuroendocrinology (1988) 0.78
Effects of neonatal treatment with MSG (monosodium glutamate) on hypothalamo-pituitary-thyroid axis in adult male rats. Histol Histopathol (1993) 0.77
Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716). Naunyn Schmiedebergs Arch Pharmacol (2008) 0.76
Marked reduction in gonadal steroid hormone levels in rats treated neonatally with monosodium L-glutamate: further evidence for disruption of hypothalamic-pituitary-gonadal axis regulation. Neuroendocrinology (1981) 0.76
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci U S A (2002) 11.11
A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res (2005) 11.02
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell (2013) 9.24
Genome sequence of Aedes aegypti, a major arbovirus vector. Science (2007) 9.19
Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther (2008) 8.83
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst (2006) 6.73
Oncogenic mutations of ALK kinase in neuroblastoma. Nature (2008) 5.80
Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy. Proc Natl Acad Sci U S A (2009) 3.58
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci U S A (2005) 2.95
Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid. Nat Med (2006) 2.78
Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J Neurosci (2007) 2.68
Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates. Mol Ther (2005) 2.48
Obesity and incidence of lung cancer: a meta-analysis. Int J Cancer (2012) 2.48
Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression. EMBO J (2002) 2.46
Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology (2007) 2.43
Anisotropic mechanosensing by mesenchymal stem cells. Proc Natl Acad Sci U S A (2006) 2.43
Electronic origin of high-temperature superconductivity in single-layer FeSe superconductor. Nat Commun (2012) 2.37
Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med (2002) 2.37
Phase diagram and electronic indication of high-temperature superconductivity at 65 K in single-layer FeSe films. Nat Mater (2013) 2.34
Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells. Int J Cancer (2004) 2.31
Long non-coding RNA: a new player in cancer. J Hematol Oncol (2013) 2.26
Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype. Blood (2003) 2.21
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol (2011) 2.19
Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron (2003) 2.17
S-S synapsis during class switch recombination is promoted by distantly located transcriptional elements and activation-induced deaminase. Immunity (2007) 2.11
Streptococcus suis sequence type 7 outbreak, Sichuan, China. Emerg Infect Dis (2006) 2.07
Boolean network simulations for life scientists. Source Code Biol Med (2008) 2.05
Differential effects of equiaxial and uniaxial strain on mesenchymal stem cells. Biotechnol Bioeng (2004) 2.05
The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC Cancer (2009) 2.01
Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci U S A (2007) 2.01
Myotube assembly on nanofibrous and micropatterned polymers. Nano Lett (2006) 2.00
Experimental demonstration of topological surface states protected by time-reversal symmetry. Phys Rev Lett (2009) 1.99
Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor beta1 stimulation. J Biol Chem (2004) 1.96
The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-β. Biomaterials (2011) 1.93
Transmission of MDR and XDR tuberculosis in Shanghai, China. PLoS One (2009) 1.93
Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid. J Neurosci (2003) 1.88
Bioactive nanofibers: synergistic effects of nanotopography and chemical signaling on cell guidance. Nano Lett (2007) 1.81
15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury. Am J Respir Crit Care Med (2009) 1.81
Rho mediates the shear-enhancement of endothelial cell migration and traction force generation. Biophys J (2004) 1.77
Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells (2010) 1.74
Adeno-associated virus-mediated gene transfer to nonhuman primate liver can elicit destructive transgene-specific T cell responses. Hum Gene Ther (2009) 1.71
A model for harmonizing flow cytometry in clinical trials. Nat Immunol (2010) 1.70
Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat Commun (2012) 1.66
Regulation of vascular smooth muscle cells by micropatterning. Biochem Biophys Res Commun (2003) 1.63
Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins. J Clin Invest (2002) 1.63
In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am (2003) 1.59
Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron (2008) 1.59
Band structure engineering in (Bi(1-x)Sb(x))(2)Te(3) ternary topological insulators. Nat Commun (2011) 1.58
Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia. Blood (2012) 1.58
Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. J Neurosci (2007) 1.58
Adeno-associated virus antibody profiles in newborns, children, and adolescents. Clin Vaccine Immunol (2011) 1.57
Synthetic clonal reproduction through seeds. Science (2011) 1.56
Biophysical regulation of epigenetic state and cell reprogramming. Nat Mater (2013) 1.55
Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey. Sci Transl Med (2011) 1.54
Cationic lipids enhance siRNA-mediated interferon response in mice. Biochem Biophys Res Commun (2005) 1.50
Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits. J Neurosci (2010) 1.49
Sporadic onset of erythermalgia: a gain-of-function mutation in Nav1.7. Ann Neurol (2006) 1.48
Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng (2006) 1.46
Vignettes: Diverse library staff offering diverse bioinformatics services. J Med Libr Assoc (2006) 1.44
PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells. Proc Natl Acad Sci U S A (2004) 1.42
Host immune responses to chronic adenovirus infections in human and nonhuman primates. J Virol (2008) 1.41
Retracted Risk miRNA screening of ovarian cancer based on miRNA functional synergistic network. J Ovarian Res (2014) 1.40
Retracted Gene-gene interaction network analysis of ovarian cancer using TCGA data. J Ovarian Res (2013) 1.40
Landau quantization of topological surface states in Bi2Se3. Phys Rev Lett (2010) 1.36
Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo. J Neurosci (2003) 1.36
Direct observation of nodes and twofold symmetry in FeSe superconductor. Science (2011) 1.35
Negative regulation of STAT3 protein-mediated cellular respiration by SIRT1 protein. J Biol Chem (2011) 1.35
Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias. Cancer Res (2009) 1.35
Arsenic-stimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide. J Clin Invest (2008) 1.33
Deaths among tuberculosis cases in Shanghai, China: who is at risk? BMC Infect Dis (2009) 1.33
Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway. Blood (2012) 1.31
Gene transfer into skeletal muscle using novel AAV serotypes. J Gene Med (2005) 1.31
Near-infrared photocatalysis based on YF3 : Yb3+,Tm3+/TiO2 core/shell nanoparticles. Chem Commun (Camb) (2010) 1.31
Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. J Neurosci (2008) 1.28
Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein. Am J Pathol (2009) 1.27
Differential regulation of Rho GTPases by beta1 and beta3 integrins: the role of an extracellular domain of integrin in intracellular signaling. J Cell Sci (2002) 1.24
Boolean modeling of transcriptome data reveals novel modes of heterotrimeric G-protein action. Mol Syst Biol (2010) 1.23
Fabrication, mechanical properties, and biocompatibility of graphene-reinforced chitosan composites. Biomacromolecules (2010) 1.22
Common and unique elements of the ABA-regulated transcriptome of Arabidopsis guard cells. BMC Genomics (2011) 1.21
Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China. Birth Defects Res A Clin Mol Teratol (2006) 1.21
Role of cell surface heparan sulfate proteoglycans in endothelial cell migration and mechanotransduction. J Cell Physiol (2005) 1.20
Synthesis of a series of novel 2,4,5-trisubstituted selenazole compounds as potential PLTP inhibitors. Bioorg Med Chem Lett (2010) 1.20
No evidence for tumorigenesis of AAV vectors in a large-scale study in mice. Mol Ther (2005) 1.20
Biomimetic collagen scaffolds for human bone cell growth and differentiation. Tissue Eng (2004) 1.19
MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2. Cancer Lett (2012) 1.19
Cell-shape regulation of smooth muscle cell proliferation. Biophys J (2009) 1.19
miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. J Hepatol (2012) 1.19
A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV. Virol J (2013) 1.19
Coexistence of blaNDM-1 with the prevalent blaOXA23 and blaIMP in pan-drug resistant Acinetobacter baumannii isolates in China. Clin Infect Dis (2011) 1.18
Open reading frame 33 of a gammaherpesvirus encodes a tegument protein essential for virion morphogenesis and egress. J Virol (2009) 1.18
Dual role of orphan nuclear receptor pregnane X receptor in bilirubin detoxification in mice. Hepatology (2005) 1.17
Inhibition of Pkhd1 impairs tubulomorphogenesis of cultured IMCD cells. Mol Biol Cell (2005) 1.17
Interplay between integrins and FLK-1 in shear stress-induced signaling. Am J Physiol Cell Physiol (2002) 1.17
A rodent model of myocardial infarction for testing the efficacy of cells and polymers for myocardial reconstruction. Nat Protoc (2006) 1.16
Beclin 1-independent autophagy induced by a Bcl-XL/Bcl-2 targeting compound, Z18. Autophagy (2010) 1.15
A WRKY transcription factor participates in dehydration tolerance in Boea hygrometrica by binding to the W-box elements of the galactinol synthase (BhGolS1) promoter. Planta (2009) 1.14